Abstract
Endometrial cancer (EC) is the most common gynecologic malignancy. MicroRNAs (miRNAs) were recently associated with carcinogenesis and progression of EC. In this review, we discuss recent advances and the emerging role of miRNAs in EC and their clinical implications, with special emphasis on the differences between deregulated miRNAs in type I and type II EC, as well as the impact of this dysregulation on EC initiation and progression.
MeSH terms
-
Drug Resistance, Neoplasm
-
Endometrial Neoplasms / diagnosis
-
Endometrial Neoplasms / genetics*
-
Endometrial Neoplasms / metabolism
-
Estrogen Receptor alpha / metabolism
-
Female
-
Gene Expression Regulation, Neoplastic*
-
Humans
-
Membrane Glycoproteins / metabolism
-
MicroRNAs / metabolism*
-
Neoplasm Metastasis
-
PTEN Phosphohydrolase / metabolism
-
Phosphatidylinositol 3-Kinases / metabolism
-
Prognosis
-
Protein-Tyrosine Kinases / metabolism
-
Receptor, trkB
-
Signal Transduction
Substances
-
ESR1 protein, human
-
Estrogen Receptor alpha
-
Membrane Glycoproteins
-
MicroRNAs
-
Protein-Tyrosine Kinases
-
Receptor, trkB
-
tropomyosin-related kinase-B, human
-
PTEN Phosphohydrolase
-
PTEN protein, human